Dengue-1 envelope protein domain III produced in Pichia pastoris: Potential use for serological diagnosis

被引:18
|
作者
Cardoso, Silvia A. [1 ]
Paixao, Vinicus F. [1 ]
Oliveira, Michelle D. [1 ]
Honda, Eduardo R. [2 ]
Oliveira, Leandro L. [1 ]
da Silva, Cynthia C. [1 ]
De Paula, Sergio O. [1 ]
机构
[1] Univ Fed Vicosa, Dept Gen Biol, Lab Mol Immunovirol, Vicosa, MG, Brazil
[2] Res Ctr Trop Med CEPEM, Porto Velho, RO, Brazil
关键词
Dengue; Domain III; Expression; Diagnosis; ELISA; Pichia pastoris; HIGH-LEVEL EXPRESSION; B SURFACE-ANTIGEN; METHYLOTROPHIC YEAST; VIRUS ENVELOPE; HETEROLOGOUS PROTEINS; BINDING; GLYCOPROTEIN; ANTIBODIES; ASSAYS;
D O I
10.1016/j.pep.2013.08.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dengue is a major international public health concern. There is no drug to treat dengue virus infections and a vaccine is yet to be licensed. The laboratory diagnosis of dengue virus infection has been greatly improved during the last decade; therefore, the main limiting factor is the production of recombinant viral antigens on a large scale. Domain III of dengue virus envelope protein contains multiplex conformation-dependent neutralizing epitopes, making it an attractive diagnostic candidate. In this work, we have demonstrated the expression of dengue virus type 1 envelope domain III protein (EDIII-D1) in methylotrophic yeast, Pichia pastoris GS115. The recombinant secreted protein (sEDIII-D1) was purified by affinity chromatography and characterized by SDS-PAGE. Purified protein was recognized in immunoblot analysis and enzyme-linked immunosorbent assay (ELISA) with dengue-infected human serum samples. In conclusion, secreted expressions of domain III protein can be obtained in P. pastoris by methanol induction. This product has the potential to be used for the diagnosis of dengue infections. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 50 条
  • [41] Thioaptamers targeting dengue virus type-2 envelope protein domain III
    Gandham, Sai Hari A.
    Volk, David E.
    Lokesh, Ganesh L. R.
    Neerathilingam, Muniasamy
    Gorenstein, David G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (03) : 309 - 315
  • [42] Cloning, expression, and purification of the N-terminal domain of the Flo1 flocculation protein from Saccharomyces cerevisiae in Pichia pastoris
    Goossens, Katty V. Y.
    De Greve, Henri
    Willaert, Ronnie G.
    PROTEIN EXPRESSION AND PURIFICATION, 2013, 88 (01) : 114 - 119
  • [43] Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein
    Mota, J
    Acosta, M
    Argotte, R
    Figueroa, R
    Méndez, A
    Ramos, C
    VACCINE, 2005, 23 (26) : 3469 - 3476
  • [44] Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
    Poddar, Ankur
    Ramasamy, Viswanathan
    Shukla, Rahul
    Rajpoot, Ravi Kant
    Arora, Upasana
    Jain, Swatantra K.
    Swaminathan, Sathyamangalam
    Khanna, Navin
    BMC BIOTECHNOLOGY, 2016, 16
  • [45] A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice
    Lazo, Laura
    Gil, Lazaro
    Lopez, Carlos
    Valdes, Iris
    Blanco, Aracelys
    Pavon, Alequis
    Romero, Yaremis
    Guzman, Maria G.
    Guillen, Gerardo
    Hermida, Lisset
    ACTA TROPICA, 2012, 124 (02) : 107 - 112
  • [46] Stereochemical features of the envelope protein Domain III of dengue virus reveals putative antigenic site in the five-fold symmetry axis
    Soares, R. O. S.
    Caliri, A.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (01): : 221 - 230
  • [47] Simple production of hydrophobin-fused domain III of dengue envelope protein and induction of neutralizing antibodies against the homotypic serotype of dengue virus
    Julieta Cerezo
    Alexandra Marisa Targovnik
    María Emilia Smith
    Daniel González Maglio
    Victoria Celina Luppo
    María Alejandra Morales
    María Victoria Miranda
    Julián Rodríguez Talou
    Biotechnology Letters, 2020, 42 : 419 - 428
  • [48] Use of Envelope Domain III Protein for the Detection of IgG Type Antibodies Specific to Zika Virus by Indirect ELISA
    Ndiaye, Oumar
    Diagne, Cheikh Tidiane
    Abd El Wahed, Ahmed
    Dia, Fatou
    Dia, Moussa
    Faye, Adama
    Leal, Silvania Da Veiga
    dos Santos, Menilita
    Mendonca, Maria da Luz de Lima
    Leite, Carolina Cardoso da Silva
    Boye, Cheikh Saad Bouh
    Bryant, Juliet E.
    Despres, Philippe
    Faye, Ousmane
    Sall, Amadou Alpha
    Faye, Oumar
    DIAGNOSTICS, 2023, 13 (03)
  • [49] Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates
    Bernard, Lidice
    Izquierdo, Alienys
    Alvarez, Mayling
    Rosario, Delfina
    Prado, Irina
    Lopez, Carlos
    Martinez, Rafael
    Castro, Jorge
    Santana, Ernidalys
    Hermida, Lisset
    Guillen, Gerardo
    Guzman, Maria G.
    ANTIVIRAL RESEARCH, 2008, 80 (02) : 194 - 199
  • [50] Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
    Chiang, Chen-Yi
    Hsieh, Chun-Hsiang
    Chen, Mei-Yu
    Tsai, Jy-Ping
    Liu, Hsueh-Hung
    Liu, Shih-Jen
    Chong, Pele
    Leng, Chih-Hsiang
    Chen, Hsin-Wei
    VACCINE, 2014, 32 (12) : 1346 - 1353